Alignment with the FDA across proposed study parameters of RESTORE, a 16-week registrational study evaluating NVG-291 in chronic tetraplegia. Primary endpoint will be the change from baseline in GRASSP Quantitative… Read More
The number of oral weight-loss / diabetes drug treatments is expanding, increasing demand for the reduction of side effects KELOWNA, BC – Lexaria Bioscience Corp., a global innovator in drug… Read More
New HemoSphere Stream™ Module expands access to continuous, noninvasive arterial waveform data across compatible bedside monitors and broader care settings, giving more clinicians real-time insight into more patients. FRANKLIN LAKES,… Read More
A bold vision for health care in British Columbia is moving closer to reality. With a recent $48 million federal investment in the Clinical Support and Research Centre, the Jim Pattison Medical… Read More
The federal government has announced $48 million in Strategic Response Fund (SRF) contributions to Providence Health Care’s Clinical Support & Research Centre (CSRC), a cornerstone of the Jim Pattison Medical Campus in… Read More
